{"pmid":32306440,"title":"Paediatric Anaesthetic implications of COVID-19 - A Review of Current Literature.","text":["Paediatric Anaesthetic implications of COVID-19 - A Review of Current Literature.","Paediatric anaesthetists have an important role to play in the management of patients suspected or confirmed to have COVID-19. In many institutions, the COVID-19 intubation teams are staffed with anaesthetists as the proceduralists working throughout the hospitals also in the ICU and Emergency Departments. As practitioners who perform aerosol generating procedures involving the airway, we are at high risk of exposure to the virus SARS-CoV-2 and need to ensure we are well-prepared and trained to manage such cases. This article reviews the relevant paediatric literature surrounding COVID-19 and summarises the key recommendations for anaesthetists involved in the care of children during this pandemic.","Paediatr Anaesth","Lee-Archer, Paul","von Ungern-Sternberg, Britta S","32306440"],"abstract":["Paediatric anaesthetists have an important role to play in the management of patients suspected or confirmed to have COVID-19. In many institutions, the COVID-19 intubation teams are staffed with anaesthetists as the proceduralists working throughout the hospitals also in the ICU and Emergency Departments. As practitioners who perform aerosol generating procedures involving the airway, we are at high risk of exposure to the virus SARS-CoV-2 and need to ensure we are well-prepared and trained to manage such cases. This article reviews the relevant paediatric literature surrounding COVID-19 and summarises the key recommendations for anaesthetists involved in the care of children during this pandemic."],"journal":"Paediatr Anaesth","authors":["Lee-Archer, Paul","von Ungern-Sternberg, Britta S"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32306440","week":"202017|Apr 20 - Apr 26","doi":"10.1111/pan.13889","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Anaesthetic"],"_version_":1664641855695880192,"score":8.518259,"similar":[{"pmid":32293715,"title":"Global guidance for surgical care during the COVID-19 pandemic.","text":["Global guidance for surgical care during the COVID-19 pandemic.","BACKGROUND: Surgeons urgently need guidance on how to deliver surgical services safely and effectively during the COVID-19 pandemic. The aim was to identify the key domains that should be considered when developing pandemic preparedness plans for surgical services. METHODS: A scoping search was conducted to identify published articles relating to management of surgical patients during pandemics. Key informant interviews were conducted with surgeons and anaesthetists with direct experience of working during infectious disease outbreaks, in order to identify key challenges and solutions to delivering effective surgical services during the COVID-19 pandemic. RESULTS: Thirteen articles were identified from the scoping search, and surgeons and anaesthetists representing 11 territories were interviewed. To mount an effective response to COVID-19, a pandemic response plan for surgical services should be developed in advance. Key domains that should be included are: provision of staff training (such as patient transfers, donning and doffing personal protection equipment, recognizing and managing COVID-19 infection); support for the overall hospital response to COVID-19 (reduction in non-urgent activities such as clinics, endoscopy, non-urgent elective surgery); establishment of a team-based approach for running emergency services; and recognition and management of COVID-19 infection in patients treated as an emergency and those who have had surgery. A backlog of procedures after the end of the COVID-19 pandemic is inevitable, and hospitals should plan how to address this effectively to ensure that patients having elective treatment have the best possible outcomes. CONCLUSION: Hospitals should prepare detailed context-specific pandemic preparedness plans addressing the identified domains. Specific guidance should be updated continuously to reflect emerging evidence during the COVID-19 pandemic.","Br J Surg","32293715"],"abstract":["BACKGROUND: Surgeons urgently need guidance on how to deliver surgical services safely and effectively during the COVID-19 pandemic. The aim was to identify the key domains that should be considered when developing pandemic preparedness plans for surgical services. METHODS: A scoping search was conducted to identify published articles relating to management of surgical patients during pandemics. Key informant interviews were conducted with surgeons and anaesthetists with direct experience of working during infectious disease outbreaks, in order to identify key challenges and solutions to delivering effective surgical services during the COVID-19 pandemic. RESULTS: Thirteen articles were identified from the scoping search, and surgeons and anaesthetists representing 11 territories were interviewed. To mount an effective response to COVID-19, a pandemic response plan for surgical services should be developed in advance. Key domains that should be included are: provision of staff training (such as patient transfers, donning and doffing personal protection equipment, recognizing and managing COVID-19 infection); support for the overall hospital response to COVID-19 (reduction in non-urgent activities such as clinics, endoscopy, non-urgent elective surgery); establishment of a team-based approach for running emergency services; and recognition and management of COVID-19 infection in patients treated as an emergency and those who have had surgery. A backlog of procedures after the end of the COVID-19 pandemic is inevitable, and hospitals should plan how to address this effectively to ensure that patients having elective treatment have the best possible outcomes. CONCLUSION: Hospitals should prepare detailed context-specific pandemic preparedness plans addressing the identified domains. Specific guidance should be updated continuously to reflect emerging evidence during the COVID-19 pandemic."],"journal":"Br J Surg","date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293715","week":"202016|Apr 13 - Apr 19","doi":"10.1002/bjs.11646","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636192733265920,"score":264.69962},{"pmid":32278168,"pmcid":"PMC7142686","title":"Practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the COVID-19 pandemic.","text":["Practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the COVID-19 pandemic.","Paediatric otolaryngology practice involves examining and operating in anatomical locations with high levels of aerosol generation and transmission of COVID-19 to treating clinicians, especially from the asymptomatic patient populations including children. During the COVID-19 pandemic all emergent otolaryngological conditions affecting the airway, oral, and nasal cavities should be managed medically where possible and any operating deferred. We present guidelines for operating on paediatric otolaryngological patients when necessary during the COVID-19 pandemic, and incorporate experience gathered during microlaryngobronchoscopy on a COVID-19 positive infant at our institution.","Int J Pediatr Otorhinolaryngol","Frauenfelder, Claire","Butler, Colin","Hartley, Ben","Cochrane, Lesley","Jephson, Chris","Nash, Robert","Hewitt, Richard","Albert, David","Wyatt, Michelle","Hall, Andrew","32278168"],"abstract":["Paediatric otolaryngology practice involves examining and operating in anatomical locations with high levels of aerosol generation and transmission of COVID-19 to treating clinicians, especially from the asymptomatic patient populations including children. During the COVID-19 pandemic all emergent otolaryngological conditions affecting the airway, oral, and nasal cavities should be managed medically where possible and any operating deferred. We present guidelines for operating on paediatric otolaryngological patients when necessary during the COVID-19 pandemic, and incorporate experience gathered during microlaryngobronchoscopy on a COVID-19 positive infant at our institution."],"journal":"Int J Pediatr Otorhinolaryngol","authors":["Frauenfelder, Claire","Butler, Colin","Hartley, Ben","Cochrane, Lesley","Jephson, Chris","Nash, Robert","Hewitt, Richard","Albert, David","Wyatt, Michelle","Hall, Andrew"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278168","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijporl.2020.110030","keywords":["covid-19","coronavirus","microlaryngobronchoscopy","paediatric airway","sars cov2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664636943968763904,"score":253.40387},{"pmid":32335900,"title":"The impact of respiratory protective equipment on difficult airway management: a randomised, crossover, simulation study.","text":["The impact of respiratory protective equipment on difficult airway management: a randomised, crossover, simulation study.","The current international coronavirus disease 19 health crisis underlines the importance of adequate and suitable personal protective equipment for clinical staff during acute airway management. This study compares the impacts of standard air purifying respirators and powered air purifying respirators during simulated difficult airway scenarios. Twenty-five anaesthetists carried out four different standardised difficult intubation drills, either unprotected (control), or wearing a standard, or a powered respirator. Treatment times and wearer comfort were determined and compared. In the wearer comfort evaluation form, operators rated mobility, noise, heat, vision, and speech intelligibility. All anaesthetists accomplished the treatment objectives of all study arms without adverse events. Total mean (SD) intubation times for the four interventions did not show significant differences between the powered and the standard respirator groups, being 16.4 (8.6) vs. 19.2 (5.2) seconds with the Airtraq, 11.4 (3.4) vs. 10.0 (2.1) seconds with the videolaryngoscope, 39.2 (4.5) vs. 40.1 (4.8) seconds with the fibreoptic bronchoscope scope, and 15.4 (5.7) vs. 15.1 (5.0) seconds for standard endotracheal intubation by direct laryngoscopy, respectively. Videolaryngoscopy achieved the shortest intubation times regardless of the respiratory protective device used. Anaesthetists rated heat and vision significantly higher in the powered respirator group; however, noise levels were perceived to be significantly lower than in the standard respirator group. We conclude that standard and powered respirators do not significantly prolong simulated advanced intubation procedures.","Anaesthesia","Schumacher, J","Arlidge, J","Dudley, D","Sicinski, M","Ahmad, I","32335900"],"abstract":["The current international coronavirus disease 19 health crisis underlines the importance of adequate and suitable personal protective equipment for clinical staff during acute airway management. This study compares the impacts of standard air purifying respirators and powered air purifying respirators during simulated difficult airway scenarios. Twenty-five anaesthetists carried out four different standardised difficult intubation drills, either unprotected (control), or wearing a standard, or a powered respirator. Treatment times and wearer comfort were determined and compared. In the wearer comfort evaluation form, operators rated mobility, noise, heat, vision, and speech intelligibility. All anaesthetists accomplished the treatment objectives of all study arms without adverse events. Total mean (SD) intubation times for the four interventions did not show significant differences between the powered and the standard respirator groups, being 16.4 (8.6) vs. 19.2 (5.2) seconds with the Airtraq, 11.4 (3.4) vs. 10.0 (2.1) seconds with the videolaryngoscope, 39.2 (4.5) vs. 40.1 (4.8) seconds with the fibreoptic bronchoscope scope, and 15.4 (5.7) vs. 15.1 (5.0) seconds for standard endotracheal intubation by direct laryngoscopy, respectively. Videolaryngoscopy achieved the shortest intubation times regardless of the respiratory protective device used. Anaesthetists rated heat and vision significantly higher in the powered respirator group; however, noise levels were perceived to be significantly lower than in the standard respirator group. We conclude that standard and powered respirators do not significantly prolong simulated advanced intubation procedures."],"journal":"Anaesthesia","authors":["Schumacher, J","Arlidge, J","Dudley, D","Sicinski, M","Ahmad, I"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335900","week":"202018|Apr 27 - May 03","doi":"10.1111/anae.15102","keywords":["cbrn","covid-19","sars-cov-2","difficult airway management","personal protective equipment"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Airtraq"],"_version_":1665172302028865536,"score":242.01076},{"pmid":32234250,"title":"Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study.","text":["Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study.","BACKGROUND: The safety of performing spinal anaesthesia for both patients and anaesthetists alike in the presence of active infection with the novel coronavirus disease 2019 (COVID-19) is unclear. Here, we report the clinical characteristics and outcomes for both patients with COVID-19 and the anaesthetists who provided their spinal anaesthesia. METHODS: Forty-nine patients with radiologically confirmed COVID-19 for Caesarean section or lower-limb surgery undergoing spinal anaesthesia in Zhongnan Hospital, Wuhan, China participated in this retrospective study. Clinical characteristics and perioperative outcomes were recorded. For anaesthesiologists exposed to patients with COVID-19 by providing spinal anaesthesia, the level of personal protective equipment (PPE) used, clinical outcomes (pulmonary CT scans), and confirmed COVID-19 transmission rates (polymerase chain reaction [PCR]) were reviewed. RESULTS: Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]). Spinal anaesthesia was not associated with cardiorespiratory compromise intraoperatively. No patients subsequently developed severe pneumonia. Of 44 anaesthetists, 37 (84.1%) provided spinal anaesthesia using Level 3 PPE. Coronavirus disease 2019 infection was subsequently confirmed by PCR in 5/44 (11.4%) anaesthetists. One (2.7%) of 37 anaesthetists who wore Level 3 PPE developed PCR-confirmed COVID-19 compared with 4/7 (57.1%) anaesthetists who had Level 1 protection in the operating theatre (relative risk reduction: 95.3% [95% confidence intervals: 63.7-99.4]; P<0.01). CONCLUSIONS: Spinal anaesthesia was delivered safely in patients with active COVID-19 infection, the majority of whom had Caesarean sections. Level 3 PPE appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients.","Br J Anaesth","Zhong, Qi","Liu, Yin Y","Luo, Qiong","Zou, Yu F","Jiang, Hai X","Li, Hui","Zhang, Jing J","Li, Zhen","Yang, Xin","Ma, Min","Tang, Li J","Chen, Ying Y","Zheng, Feng","Ke, Jian J","Zhang, Zong Z","32234250"],"abstract":["BACKGROUND: The safety of performing spinal anaesthesia for both patients and anaesthetists alike in the presence of active infection with the novel coronavirus disease 2019 (COVID-19) is unclear. Here, we report the clinical characteristics and outcomes for both patients with COVID-19 and the anaesthetists who provided their spinal anaesthesia. METHODS: Forty-nine patients with radiologically confirmed COVID-19 for Caesarean section or lower-limb surgery undergoing spinal anaesthesia in Zhongnan Hospital, Wuhan, China participated in this retrospective study. Clinical characteristics and perioperative outcomes were recorded. For anaesthesiologists exposed to patients with COVID-19 by providing spinal anaesthesia, the level of personal protective equipment (PPE) used, clinical outcomes (pulmonary CT scans), and confirmed COVID-19 transmission rates (polymerase chain reaction [PCR]) were reviewed. RESULTS: Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]). Spinal anaesthesia was not associated with cardiorespiratory compromise intraoperatively. No patients subsequently developed severe pneumonia. Of 44 anaesthetists, 37 (84.1%) provided spinal anaesthesia using Level 3 PPE. Coronavirus disease 2019 infection was subsequently confirmed by PCR in 5/44 (11.4%) anaesthetists. One (2.7%) of 37 anaesthetists who wore Level 3 PPE developed PCR-confirmed COVID-19 compared with 4/7 (57.1%) anaesthetists who had Level 1 protection in the operating theatre (relative risk reduction: 95.3% [95% confidence intervals: 63.7-99.4]; P<0.01). CONCLUSIONS: Spinal anaesthesia was delivered safely in patients with active COVID-19 infection, the majority of whom had Caesarean sections. Level 3 PPE appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients."],"journal":"Br J Anaesth","authors":["Zhong, Qi","Liu, Yin Y","Luo, Qiong","Zou, Yu F","Jiang, Hai X","Li, Hui","Zhang, Jing J","Li, Zhen","Yang, Xin","Ma, Min","Tang, Li J","Chen, Ying Y","Zheng, Feng","Ke, Jian J","Zhang, Zong Z"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234250","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.bja.2020.03.007","keywords":["covid-19","infection","intra-spinal anaesthesia","perioperative clinical characteristics","surgery"],"source":"PubMed","topics":["Diagnosis","Transmission"],"weight":1,"locations":["Zhongnan Hospital","Wuhan","China","Caesarean"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ropivacaine"],"_version_":1664638354166120449,"score":239.38046},{"pmid":32173188,"pmcid":"PMC7118614","title":"[Recommendations on the clinical management of the COVID-19 infection by the <<new coronavirus>> SARS-CoV2. Spanish Paediatric Association working group].","text":["[Recommendations on the clinical management of the COVID-19 infection by the <<new coronavirus>> SARS-CoV2. Spanish Paediatric Association working group].","On 31 December 2019, the Wuhan Municipal Committee of Health and Healthcare (Hubei Province, China) reported that there were 27 cases of pneumonia of unknown origin with symptoms starting on the 8 December. There were 7 serious cases with common exposure in market with shellfish, fish, and live animals, in the city of Wuhan. On 7 January 2020, the Chinese authorities identified that the agent causing the outbreak was a new type of virus of the Coronaviridae family, temporarily called <<new coronavirus>>, 2019-nCoV. On January 30th, 2020, the World Health Organisation (WHO) declared the outbreak an International Emergency. On 11 February 2020 the WHO assigned it the name of SARS-CoV2 and COVID-19 (SARS-CoV2 and COVID-19). The Ministry of Health summoned the Specialties Societies to prepare a clinical protocol for the management of COVID-19. The Spanish Paediatric Association appointed a Working Group of the Societies of Paediatric Infectious Diseases and Paediatric Intensive Care to prepare the present recommendations with the evidence available at the time of preparing them.","An Pediatr (Barc)","Calvo, Cristina","Garcia Lopez-Hortelano, Milagros","de Carlos Vicente, Juan Carlos","Vazquez Martinez, Jose Luis","32173188"],"abstract":["On 31 December 2019, the Wuhan Municipal Committee of Health and Healthcare (Hubei Province, China) reported that there were 27 cases of pneumonia of unknown origin with symptoms starting on the 8 December. There were 7 serious cases with common exposure in market with shellfish, fish, and live animals, in the city of Wuhan. On 7 January 2020, the Chinese authorities identified that the agent causing the outbreak was a new type of virus of the Coronaviridae family, temporarily called <<new coronavirus>>, 2019-nCoV. On January 30th, 2020, the World Health Organisation (WHO) declared the outbreak an International Emergency. On 11 February 2020 the WHO assigned it the name of SARS-CoV2 and COVID-19 (SARS-CoV2 and COVID-19). The Ministry of Health summoned the Specialties Societies to prepare a clinical protocol for the management of COVID-19. The Spanish Paediatric Association appointed a Working Group of the Societies of Paediatric Infectious Diseases and Paediatric Intensive Care to prepare the present recommendations with the evidence available at the time of preparing them."],"journal":"An Pediatr (Barc)","authors":["Calvo, Cristina","Garcia Lopez-Hortelano, Milagros","de Carlos Vicente, Juan Carlos","Vazquez Martinez, Jose Luis"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32173188","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.anpedi.2020.02.001","keywords":["2019-ncov","covid-19","children","coronavirus","infeccion respiratoria","ninos","respiratory infection","sars-cov2"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["China","Wuhan","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874664951808,"score":198.12724}]}